A new study has revealed that women may be at a 31% higher risk of developing long Covid compared to men, with women aged 40-55 years being particularly vulnerable. The research, part of the ‘RECOVER’ trial, was published in The Journal of the American Medical Association (JAMA) Network Open.

The study found that within this age group, the risk is even more pronounced—42% among menopausal women and 45% among non-menopausal women. These findings suggest that hormonal factors may play a significant role in the development of long Covid.

Long Covid, a condition where symptoms such as fatigue, brain fog, and difficulty concentrating persist long after the acute phase of Covid-19 has passed, is estimated to affect about a third of those who have been infected with the virus. The condition, which continues to puzzle medical experts, remains a topic of ongoing global research to better understand its causes and potential treatments.

This study highlights the need for targeted interventions for women, especially those in the 40-55 age bracket, to help manage and prevent the prolonged effects of long Covid.